• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

For patients with chronic asthma not controlled with inhaled corticosteroids alone, long-acting β-agonists are associated with fewer exacerbations than leukotriene receptor agonists.

作者信息

Colice Gene

机构信息

Department of Medicine, George Washington University School of Medicine, Washington DC, USA.

出版信息

Evid Based Med. 2014 Oct;19(5):174. doi: 10.1136/eb-2014-110032. Epub 2014 Jun 4.

DOI:10.1136/eb-2014-110032
PMID:24917602
Abstract
摘要

相似文献

1
For patients with chronic asthma not controlled with inhaled corticosteroids alone, long-acting β-agonists are associated with fewer exacerbations than leukotriene receptor agonists.对于仅使用吸入性糖皮质激素无法控制的慢性哮喘患者，长效β受体激动剂比白三烯受体激动剂引发的病情加重次数更少。
Evid Based Med. 2014 Oct;19(5):174. doi: 10.1136/eb-2014-110032. Epub 2014 Jun 4.
2
[PHARMACOGENETIC MARKERS OF THE EFFECTIVENESS OF TREATMENT OF CHILDREN WITH ATOPIC BRONCHIAL ASTHMA.].[儿童过敏性支气管哮喘治疗效果的药物遗传学标志物。]
Eksp Klin Farmakol. 2016;79(11):35-40.
3
[Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].中度持续性哮喘的治疗：吸入性糖皮质激素联合长效β2肾上腺素能激动剂（支气管扩张剂），然后联合白三烯受体拮抗剂（抗炎药）；“第三步困境”
Ned Tijdschr Geneeskd. 2003 Aug 30;147(35):1681-5.
4
Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis.用于减少成人哮喘发作的药物治疗：一项系统评价与荟萃分析。
JAMA. 2004 Jul 21;292(3):367-76. doi: 10.1001/jama.292.3.367.
5
Pharmacologic interventions to reduce the risk of asthma exacerbations.降低哮喘急性加重风险的药物干预措施。
Proc Am Thorac Soc. 2004;1(2):105-8. doi: 10.1513/pats.2306028.
6
Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.评估吸入性糖皮质激素、长效β2受体激动剂和白三烯调节剂的“三联疗法”对哮喘的疗效。
Chest. 2006 Jul;130(1):301-2. doi: 10.1378/chest.130.1.301.
7
Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study.吸入皮质类固醇治疗的儿童升级治疗方案的疗效比较：一项历史性队列研究。
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1082-1090.e7. doi: 10.1016/j.jaip.2016.12.028. Epub 2017 Mar 27.
8
Combination therapy of bronchial asthma.支气管哮喘的联合治疗
Allergy Asthma Proc. 2001 Jul-Aug;22(4):217-20.
9
Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.白三烯受体拮抗剂和长效β2肾上腺素受体激动剂与吸入性糖皮质激素联合治疗哮喘的耐受性概况：一项综述
J Asthma. 2007 Jul-Aug;44(6):411-22. doi: 10.1080/02770900701247178.
10
Mepolizumab efficacy in patients with severe eosinophilic asthma receiving different controller therapies.美泊利珠单抗在接受不同控制疗法的重度嗜酸性粒细胞性哮喘患者中的疗效。
J Allergy Clin Immunol. 2017 Nov;140(5):1464-1466.e4. doi: 10.1016/j.jaci.2017.06.010. Epub 2017 Jul 4.